FDA Inspection 1167505 — Cambrex Profarmaco Milano Srl
The FDA completed an inspection of Cambrex Profarmaco Milano Srl on Oct 1, 2021 in Paullo. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 1, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Paullo (Italy)
Additional details
Mutual Recognition Agreement (MRA)